PT Pabrik Kertas Tjiwi Kimia Tbk (TKIM) Fair Value & Analysis
Basic Materials · ID · Market cap 16.4T IDR
Analysis
PT Pabrik Kertas Tjiwi Kimia Tbk (TKIM) currently trades at 5,950 IDR, while our model-based Fair Value estimate is 8,437 IDR — implying the stock looks roughly 41.8% undervalued today. We read business quality at 95/100 (high quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
About the company
PT Pabrik Kertas Tjiwi Kimia Tbk manufactures and sells writing and printing paper products in Asia, Africa, Europe, the Middle East, the United States, and internationally. The company operates in two segments, Cultural Paper Products, and Industrial Paper Products and Other. It offers white grade paper products, including uncoated woodfree, uncoated photocopy, coated carbonless, specialty grease proof, specialty kraft paper, specialty drawing p., and specialty briefcard products; brown grade paper comprising medium fluting, test liner, and core board products; and stationery products, such as writing products, writing product spirals, writing product pads, writing product loose leaves, writing product hard cover books, office product envelopes, office product register rolls, office product plotters, and office product computer papers. The company also provides chemicals, including sodium hypochlorite, hydrochloric acid, chlorine liquid, calcium chloride, caustic soda liquid, caust…
Open the full interactive analysis →
Similar stocks
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.